These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation. Henstridge CM; Balenga NA; Ford LA; Ross RA; Waldhoer M; Irving AJ FASEB J; 2009 Jan; 23(1):183-93. PubMed ID: 18757503 [TBL] [Abstract][Full Text] [Related]
6. Peptide targeting of lysophosphatidylinositol-sensing GPR55 for osteoclastogenesis tuning. Mosca MG; Mangini M; Cioffi S; Barba P; Mariggiò S Cell Commun Signal; 2021 Apr; 19(1):48. PubMed ID: 33902596 [TBL] [Abstract][Full Text] [Related]
7. Glycerophosphodiesterase 3 (GDE3) is a lysophosphatidylinositol-specific ectophospholipase C acting as an endocannabinoid signaling switch. Briand-Mésange F; Pons V; Allart S; Masquelier J; Chicanne G; Beton N; Payrastre B; Muccioli GG; Ausseil J; Davignon JL; Salles JP; Chap H J Biol Chem; 2020 Nov; 295(46):15767-15781. PubMed ID: 32917725 [TBL] [Abstract][Full Text] [Related]
8. The GPR55 agonist lysophosphatidylinositol relaxes rat mesenteric resistance artery and induces Ca(2+) release in rat mesenteric artery endothelial cells. AlSuleimani YM; Hiley CR Br J Pharmacol; 2015 Jun; 172(12):3043-57. PubMed ID: 25652040 [TBL] [Abstract][Full Text] [Related]
9. The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55. Yamashita A; Oka S; Tanikawa T; Hayashi Y; Nemoto-Sasaki Y; Sugiura T Prostaglandins Other Lipid Mediat; 2013 Dec; 107():103-16. PubMed ID: 23714700 [TBL] [Abstract][Full Text] [Related]
10. Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands. Kapur A; Zhao P; Sharir H; Bai Y; Caron MG; Barak LS; Abood ME J Biol Chem; 2009 Oct; 284(43):29817-27. PubMed ID: 19723626 [TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidylinositol-induced activation of the cation channel TRPV2 triggers glucagon-like peptide-1 secretion in enteroendocrine L cells. Harada K; Kitaguchi T; Kamiya T; Aung KH; Nakamura K; Ohta K; Tsuboi T J Biol Chem; 2017 Jun; 292(26):10855-10864. PubMed ID: 28533434 [TBL] [Abstract][Full Text] [Related]
12. GPR55, a lysophosphatidylinositol receptor with cannabinoid sensitivity? Nevalainen T; Irving AJ Curr Top Med Chem; 2010; 10(8):799-813. PubMed ID: 20370712 [TBL] [Abstract][Full Text] [Related]
13. GPR55-dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans. Liu B; Song S; Ruz-Maldonado I; Pingitore A; Huang GC; Baker D; Jones PM; Persaud SJ Diabetes Obes Metab; 2016 Dec; 18(12):1263-1273. PubMed ID: 27561953 [TBL] [Abstract][Full Text] [Related]
14. GPR55-dependent and -independent ion signalling in response to lysophosphatidylinositol in endothelial cells. Bondarenko A; Waldeck-Weiermair M; Naghdi S; Poteser M; Malli R; Graier WF Br J Pharmacol; 2010 Sep; 161(2):308-20. PubMed ID: 20735417 [TBL] [Abstract][Full Text] [Related]
15. A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell function. Kargl J; Brown AJ; Andersen L; Dorn G; Schicho R; Waldhoer M; Heinemann A J Pharmacol Exp Ther; 2013 Jul; 346(1):54-66. PubMed ID: 23639801 [TBL] [Abstract][Full Text] [Related]